BioRender

Federal funding cuts made this a challenging year for U.S. academic researchers. That’s why earlier this year, we launched the BioRender Grant Support Initiative to help scientists strengthen their funding applications. We’re excited to celebrate the winners behind more than $1B in awarded and proposed research funding: https://lnkd.in/gzmPZgrr Special thanks to Life Science Editors for providing expert grant editing support as part of this initiative.

Meet David Campos, BioRender’s new Chief Business Officer! Over the past decade, David has led global teams across tech and finance. He mostly recently served as CFO at Xepelin, where he scaled the company from 80 to over 650 employees and raised more than $300M in debt and equity funding, and previously held roles at Huckleberry Technology, Orbis Investments and McKinsey & Company.

Here’s your 2025 Grant Survival Toolkit. With grant season approaching and funding competition at a high, this resource is designed to help your proposal stand out and strengthen your chances of success. Want all the tips? Read the full toolkit we created with Angela Andersen, available now on our blog. https://lnkd.in/gGiHUqDY

Want expert help with your next grant application? We’re offering personalized, professional support to help you put your best foot forward. The deadline is August 20th, 2025. Learn more and apply here: https://lnkd.in/gdQEhRTn 

Meet our new Chief Revenue Officer, Chris Hemberger! As we build a world-class commercial organization at BioRender, Chris will be leading the charge into our next chapter of growth. Over the past 15+ years, he’s scaled teams from the ground up, led organizations of 250+ people, and helped drive revenue growth at companies scaling from $10M to over $1.2B. We asked Chris what he’s most excited about and here’s what he had to say:

We’re thrilled to welcome Dr. Kiran Rao as BioRender’s new Chief Operating Officer! Kiran began his career as a physician before spending the next two decades leading in strategy consulting, investing, and operations. Joining BioRender brings his journey full circle, reconnecting him with his roots in science. We asked Kiran what inspired him to join BioRender, here’s what he had to say:

“As I positioned each element and drew each connection, I got stuck. A detail was unclear, a mechanism was missing…these weren't simply holes in my knowledge, they were active areas of scientific debate.” – Dr. Chi Dang Before the experiment or the paper, Dr. Chi Van Dang sketches in BioRender. Not just to illustrate, but to think. It helps him uncover knowledge gaps, test his understanding, and form new hypotheses. As CEO of the Ludwig Institute for Cancer Research and a Bloomberg Distinguished Professor at Johns Hopkins, Dr. Chi Dang relies on visual thinking as part of the scientific process. Discover how visual thinking shapes his research: https://lnkd.in/gwhjq5p9

We’re excited to launch the BioRender Grant Support Initiative, offering nearly $200,000 in expert resources to help researchers submit stronger, more competitive funding proposals! With a community of over 4 million scientists, we’ve heard from many of you about the ongoing challenges in the U.S. funding landscape. You’re working longer hours, submitting more grants, and doing everything you can to keep science moving forward. Applications are open through August 20, 2025: https://lnkd.in/gzPuZ3JQ

How is U.S. science being shaped under President Trump’s second term? 300+ researchers shared how they’re adapting to growing federal funding uncertainty. Join our upcoming live panel to hear their strategies on: ✔ Navigating alternative funding sources ✔ What industry partners and funders are looking for in 2025 ✔ How to build long-term funding resilience Register here: https://lnkd.in/gQwXqPTa

What does it take to build long-term funding resilience in 2025? Join leaders and founders from Novartis, Life Science Editors, and the Science Philanthropy Accelerator for Research and Collaboration (SPARC) for a live panel on “the Funding Survival Guide.” We'll discuss: ✔ How to craft more competitive proposals ✔ How to form strategic industry partnerships ✔ How to secure funding beyond federal grants